Bakris GL - Search Results

1

The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension.

Ruilope L, Kjeldsen SE, de la Sierra A, Mancia G, Ruggenenti P, Stergiou GS, Bakris GL, Giles TD. Ruilope L, et al. Among authors: bakris gl. Blood Press. 2007;16(2):72-9. doi: 10.1080/08037050701338985. Blood Press. 2007. PMID: 17612904 Free article. Review.

2

Defining the antihypertensive properties of the angiotensin receptor blocker telmisartan by a practice-based clinical trial.

Giles TD, Bakris GL, Smith DH, Davidai G, Weber MA. Giles TD, et al. Among authors: bakris gl. Am J Hypertens. 2003 Jun;16(6):460-6. doi: 10.1016/s0895-7061(03)00848-3. Am J Hypertens. 2003. PMID: 12799094 Clinical Trial.

3

Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker.

Weber MA, Bakris GL, Neutel JM, Davidai G, Giles TD. Weber MA, et al. Among authors: bakris gl. J Clin Hypertens (Greenwich). 2003 Sep-Oct;5(5):322-9. doi: 10.1111/j.1524-6175.2003.02671.x. J Clin Hypertens (Greenwich). 2003. PMID: 14564132 Free PMC article.

4

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW; INVEST Investigators. Pepine CJ, et al. Among authors: bakris gl. JAMA. 2003 Dec 3;290(21):2805-16. doi: 10.1001/jama.290.21.2805. JAMA. 2003. PMID: 14657064 Clinical Trial.

5

Diabetes and chronic kidney disease: tragedy and challenge.

Chua DY, Bakris GL. Chua DY, et al. Among authors: bakris gl. Blood Purif. 2004;22(1):130-5. doi: 10.1159/000074933. Blood Purif. 2004. PMID: 14732821 Review.

6

Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.

Ruilope LM, Usan L, Segura J, Bakris GL. Ruilope LM, et al. Among authors: bakris gl. J Hypertens. 2004 Jan;22(1):217-22. doi: 10.1097/00004872-200401000-00032. J Hypertens. 2004. PMID: 15106814 Clinical Trial.

7

Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.

Bakris GL, Gaxiola E, Messerli FH, Mancia G, Erdine S, Cooper-DeHoff R, Pepine CJ; INVEST Investigators. Bakris GL, et al. Hypertension. 2004 Nov;44(5):637-42. doi: 10.1161/01.HYP.0000143851.23721.26. Epub 2004 Sep 20. Hypertension. 2004. PMID: 15381674

8

Implications of albuminuria on kidney disease progression.

Bakris GL. Bakris GL. J Clin Hypertens (Greenwich). 2004 Nov;6(11 Suppl 3):18-22. doi: 10.1111/j.1524-6175.2004.04065.x. J Clin Hypertens (Greenwich). 2004. PMID: 15538107 Free PMC article. Review.

9

Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial.

White WB, Weber MA, Davidai G, Neutel JM, Bakris GL, Giles T. White WB, et al. Among authors: bakris gl. Blood Press Monit. 2005 Jun;10(3):157-63. doi: 10.1097/00126097-200506000-00008. Blood Press Monit. 2005. PMID: 15923818 Clinical Trial.

10

Angiotensin receptor blockers: therapeutic targets and cardiovascular protection.

Ruilope LM, Rosei EA, Bakris GL, Mancia G, Poulter NR, Taddei S, Unger T, Volpe M, Waeber B, Zannad F. Ruilope LM, et al. Among authors: bakris gl. Blood Press. 2005;14(4):196-209. doi: 10.1080/08037050500230227. Blood Press. 2005. PMID: 16126553 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

839 results

Search Page

Filters